Literature DB >> 29229766

Mesenchymal Stromal Cells for AKI after Cardiac Surgery.

Norberto Perico1, Federica Casiraghi2, Giuseppe Remuzzi2,3,4.   

Abstract

Keywords:  AKI; CKD; Mesenchymal stromal cells

Mesh：

Year:  2017        PMID： 29229766      PMCID： PMC5748931          DOI： 10.1681/ASN.2017111207

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  21 in total

Review 1.  Mesenchymal stem cells: immune evasive, not immune privileged.

Authors:  James A Ankrum; Joon Faii Ong; Jeffrey M Karp
Journal:  Nat Biotechnol       Date:  2014-02-23       Impact factor: 54.908

2.  Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery.

Authors:  Madhav Swaminathan; Mark Stafford-Smith; Glenn M Chertow; David G Warnock; Viken Paragamian; Robert M Brenner; François Lellouche; Alison Fox-Robichaud; Mohamed G Atta; Spencer Melby; Ravindra L Mehta; Ron Wald; Subodh Verma; C David Mazer
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

3.  Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery.

Authors:  Rajendra H Mehta; Joshua D Grab; Sean M O'Brien; Charles R Bridges; James S Gammie; Constance K Haan; T Bruce Ferguson; Eric D Peterson
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

Review 4.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

Review 5.  Mesenchymal stem cells and kidney repair.

Authors:  Marina Morigi; Ariela Benigni
Journal:  Nephrol Dial Transplant       Date:  2012-12-20       Impact factor: 5.992

6.  Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.

Authors:  Chirag R Parikh; Heather Thiessen-Philbrook; Amit X Garg; Deepak Kadiyala; Michael G Shlipak; Jay L Koyner; Charles L Edelstein; Prasad Devarajan; Uptal D Patel; Michael Zappitelli; Catherine D Krawczeski; Cary S Passik; Steven G Coca
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 8.237

Review 7.  Multipotent mesenchymal stromal cell therapy and risk of malignancies.

Authors:  Federica Casiraghi; Giuseppe Remuzzi; Mauro Abbate; Norberto Perico
Journal:  Stem Cell Rev Rep       Date:  2013-02       Impact factor: 5.739

8.  Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery.

Authors:  Lars Englberger; Rakesh M Suri; Zhuo Li; Edward T Casey; Richard C Daly; Joseph A Dearani; Hartzell V Schaff
Journal:  Crit Care       Date:  2011-01-13       Impact factor: 9.097

9.  Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery.

Authors:  Kate Birnie; Veerle Verheyden; Domenico Pagano; Moninder Bhabra; Kate Tilling; Jonathan A Sterne; Gavin J Murphy
Journal:  Crit Care       Date:  2014-11-20       Impact factor: 9.097

10.  Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury.

Authors:  Simon Sawhney; Angharad Marks; Nick Fluck; Adeera Levin; David McLernon; Gordon Prescott; Corri Black
Journal:  Kidney Int       Date:  2017-04-14       Impact factor: 10.612
View more
  2 in total

1.  Effects of Mesenchymal Stem Cells Therapy on Cardiovascular Risk Factors in Experimental Diabetic Kidney Disease.

Authors:  Einas Nagib Hussein; Gehane M Hamed; Ansam A Seif; Mona A Ahmed; Fatma Abd Elkarim Abu Zahra
Journal:  Can J Kidney Health Dis       Date:  2020-10-22

2.  Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord.

Authors:  Sermporn Thaweesapphithak; Chairat Tantrawatpan; Pakpoom Kheolamai; Duangrat Tantikanlayaporn; Sittiruk Roytrakul; Sirikul Manochantr
Journal:  Stem Cell Res Ther       Date:  2019-03-07       Impact factor: 6.832
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.